IDH mutations and methylation of the O6-methylguanine-DNA methyltransferase (MGMT) promoter, both important prognostic factors in glioma, occurred in more than 70% of LGG [30] and 50% of grade IV astrocytoma [31], respectively. Here, MGMT is linked to central nervous system cancer.